Ananda Ghosh
Stock Analyst at HC Wainwright & Co.
(4.58)
# 315
Out of 5,093 analysts
16
Total ratings
66.67%
Success rate
28.05%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DYN Dyne Therapeutics | Maintains: Buy | $46 → $60 | $19.73 | +204.11% | 2 | Dec 8, 2025 | |
| MAZE Maze Therapeutics | Maintains: Buy | $50 → $60 | $39.89 | +50.41% | 4 | Dec 3, 2025 | |
| PEPG PepGen | Maintains: Buy | $18 → $20 | $5.68 | +252.11% | 3 | Nov 13, 2025 | |
| RNA Avidity Biosciences | Downgrades: Neutral | $87 → $72 | $71.42 | +0.82% | 2 | Oct 27, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $24 | $4.44 | +440.54% | 2 | Oct 9, 2025 | |
| SKYE Skye Bioscience | Initiates: Buy | $20 | $1.18 | +1,594.92% | 1 | Sep 30, 2025 | |
| ANNX Annexon | Reiterates: Buy | $14 | $4.91 | +185.13% | 1 | Aug 15, 2025 | |
| GPCR Structure Therapeutics | Maintains: Buy | $75 → $60 | $67.34 | -10.90% | 1 | Aug 7, 2025 |
Dyne Therapeutics
Dec 8, 2025
Maintains: Buy
Price Target: $46 → $60
Current: $19.73
Upside: +204.11%
Maze Therapeutics
Dec 3, 2025
Maintains: Buy
Price Target: $50 → $60
Current: $39.89
Upside: +50.41%
PepGen
Nov 13, 2025
Maintains: Buy
Price Target: $18 → $20
Current: $5.68
Upside: +252.11%
Avidity Biosciences
Oct 27, 2025
Downgrades: Neutral
Price Target: $87 → $72
Current: $71.42
Upside: +0.82%
Inventiva
Oct 9, 2025
Maintains: Buy
Price Target: $20 → $24
Current: $4.44
Upside: +440.54%
Skye Bioscience
Sep 30, 2025
Initiates: Buy
Price Target: $20
Current: $1.18
Upside: +1,594.92%
Annexon
Aug 15, 2025
Reiterates: Buy
Price Target: $14
Current: $4.91
Upside: +185.13%
Structure Therapeutics
Aug 7, 2025
Maintains: Buy
Price Target: $75 → $60
Current: $67.34
Upside: -10.90%